Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
CMPX holding history
Compass Therapeutics, Inc. in every 13F filed by Enavate Sciences GP, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CMPX overviewAll 13F holders of CMPXFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,788,150
- Value
- $17.1M
- % of portfolio
- 4.9%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,788,150 | $17.1M | 4.9% | 00.0% | Unchanged | Holders |
| Q1 2026 | 7,788,150 | $41.2M | 11.7% | 00.0% | Unchanged | Holders |
| Q4 2025 | 7,788,150 | $41.8M | 8.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 7,788,150 | $27.3M | 8.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 7,788,150 | $20.2M | 11.5% | 00.0% | Unchanged | Holders |
| Q1 2025 | 7,788,150 | $14.8M | 11.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 7,788,150 | $11.3M | 8.1% | – | No prior filing | Holders |